WKN: 946008 / ISIN: INE159A01016

prices + charts + realtime		news + analysis	fundamental	company	corresponding shares	action
price + Chart	chart (large)	news + ad-hoc	balance sheet/p&l	fixed dates	certificates	portfolio#add_instrument_to#depot
times + sale	chart comparison	analysis	detailnavigation#shares#estimates	profile	warrants	portfolio#add_instrument_to#watchlist
stock exchange	realtime push	stock price appreciation potential	dividend/annual shareholders' meeting		knockouts
historic			analysis

prices + charts + realtime
price + Chart
chart (large)
times + sale
chart comparison
stock exchange
realtime push
historic

news + analysis
news + ad-hoc
analysis
stock price appreciation potential

fundamental
balance sheet/p&l
detailnavigation#shares#estimates
dividend/annual shareholders' meeting
analysis

company
fixed dates
profile

corresponding shares
certificates
warrants
knockouts

action
portfolio#add_instrument_to#depot
portfolio#add_instrument_to#watchlist

GlaxoSmithKline Pharmaceuticals times and sales (BOM)

time	price	transaction volume	transaction volume graphical
Times and Sales derivativetimesandsales: notass

retreat of prices	increase in prices	no change in prices
shares#timesandsales#barchartdescription

news about GlaxoSmithKline Pharmaceuticals

02.08.2026 07:01:06

Ausblick: GlaxoSmithKline Pharmaceuticals legt Zahlen zum jüngsten Quartal vor

analysis to GlaxoSmithKline Pharmaceuticals

more news by category

24.09.2026 18:11:27		Saint, sinner or feminist icon: How Mary Magdalene's image evolved through time
24.09.2026 18:11:27		Jews once lived lived here: When houses tell stories
24.09.2026 18:09:10		These Analysts Revise Their Forecasts On Paychex Following Q1 Results
24.09.2026 18:08:27		Carnival Analysts Cut Price Targets Ahead of Q3 Earnings
24.09.2026 18:07:27		Werner Herzog: Germany's wild man of cinema is back
24.09.2026 18:07:27		Egg freezing in women's football: Choice or pressure?
24.09.2026 18:07:27		Elversberg: Bundesliga newcomers from tiny town make waves
24.09.2026 18:07:27		PISA 2025 results: Reading and math scores plummet worldwide
24.09.2026 18:07:27		The Bayeux Tapestry in London: What's behind the hype?
24.09.2026 18:07:27		How Belarusians still find hope in a silenced country
24.09.2026 18:07:27		Can Iran replace sea trade with land routes?
24.09.2026 18:07:27		Women's Basketball World Cup: Can Germany harness a boom?
24.09.2026 18:05:00		Rivian vs. the S&P 500: Which Investment Wins Through 2030?
24.09.2026 18:03:27		Gamescom 2026: What's next for the gaming industry?
24.09.2026 18:03:27		Germany's military wants to recruit tech-savvy gamers
24.09.2026 18:03:27		Influential humanists: These are the winners of the Goethe Medal 2026
24.09.2026 18:03:27		Inside the sea cucumber smuggling boom
24.09.2026 18:03:27		Can new Apple CEO John Ternus fix the tech giant's AI woes?
24.09.2026 18:03:27		How Volkswagen's huge workforce became a costly burden
24.09.2026 18:03:27		2026 Beethoven Festival evokes a sense of home
24.09.2026 18:03:27		The hidden environmental cost of AI data centers
24.09.2026 18:03:17		CoreWeave vs. QuantumScape: Which Stock Is a Better Investment, the AI Giant or the EV Battery Upstart?
24.09.2026 18:00:29		If You Invested $100 In Take-Two Interactive Stock 20 Years Ago, You Would Have This Much Today
24.09.2026 18:00:05		Mortgage Rates Hit 7% as Iran War Fallout Crushes a Weak Housing Market
24.09.2026 18:00:00		I spend my time and money caring for my aging mother — yet she gave my brother $100,000. Should I pull back?
24.09.2026 18:00:00		SCHD Is Down From Its All-Time High. Here's Why I'm Not Selling.
24.09.2026 17:58:27		Rivian Stock Pauses Thursday: What's Going On?
24.09.2026 17:57:24		Why Meta Platforms Stock Keeps Going Up
24.09.2026 17:55:02		QUICK SPARK: The TLT ETF Tracking Long Duration Bonds Hits New Record Low
24.09.2026 17:45:24		Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today
24.09.2026 17:45:02		Caterpillar vs. Honeywell International: Which Industrials Stock Is a Better Buy in 2026?
24.09.2026 17:44:26		Kyverna Therapeutics Therapy Delivers Sustained Relief in Rare Neurological Conditions
24.09.2026 17:43:56		XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration
24.09.2026 17:42:44		BlackBerry Raises Full-Year Outlook Again
24.09.2026 17:42:29		Save 15% Off a Japanese eSIM Data Plan With Ubigi and Our Exclusive Code
24.09.2026 17:42:08		The court ordered Trump to restore access for CNN, MS Now and Politico last night.
24.09.2026 17:41:30		Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy
24.09.2026 17:40:45		Boeing Gets Fresh Demand Boost While Union Vote, Weak Technicals Loom
24.09.2026 17:39:00		Rechenzentren im All: Google-Satellit mit vier KI-Beschleunigern vor dem Start
24.09.2026 17:36:28		Transcript: H.B. Fuller Q3 2026 Earnings Conference Call
24.09.2026 17:35:35		General Mills Posts Q1 Beat; There’s Still ‘More Work To Be Done,’ Analysts Say
24.09.2026 17:34:32		Google Moves Up its Space Data Center Timeline — Project Suncatcher Launches Oct. 1
24.09.2026 17:34:09		Bitcoin Bets Go Into Overdrive As MSTR, Leveraged ETFs Surge
24.09.2026 17:32:23		Why Is Viking Therapeutics Stock Trading Down Thursday?
24.09.2026 17:32:08		Forget PEPE: PENGU Could Outrun DOGE, SHIB With a 1,200% Rally
24.09.2026 17:30:33		Here's Why Viking Therapeutics Shares Slumped Today
24.09.2026 17:30:25		Here's How Much $100 Invested In Analog Devices 20 Years Ago Would Be Worth Today
24.09.2026 17:30:00		Warren Buffett Says "Father Time Always Wins." History Says Investors Who Do This 1 Thing Will Win Out Anyway.
24.09.2026 17:18:04		MPs to consider whether Bank of England’s remit is ‘fit for purpose’
24.09.2026 17:15:33		If You Invested $100 In Wheaton Precious Metals Stock 20 Years Ago, You Would Have This Much Today

paging#first paging#back | ... | 32 | 33 | 34 | 35 | paging#next

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

footer#furtherstocks: Infosys Bank of India Dematerialised Mipco Seamless Rings JHS Svendgaard Laboratories Arvind

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 81% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

portfolio#entry#portfolio_name: portfolio#entry#watchlist_name:
portfolio#entry#portfolio:
portfolio#entry#name:
portfolio#entry#instrumenttype:
portfolio#entry#identifier:
portfolio#entry#exchange:
portfolio#entry#size:
portfolio#entry#current_quote:
portfolio#entry#current_quotetime:
portfolio#entry#buying_price:
portfolio#entry#buying_date:	29.09.2026 03:03:31
portfolio#entry#buying_worth:	EUR
	portfolio#addinstrumenttoportfolio#submit

GlaxoSmithKline Pharmaceuticals share#snapshot#suffix

WKN: 946008 / ISIN: INE159A01016

GlaxoSmithKline Pharmaceuticals times and sales (BOM)

Times and Sales

news about GlaxoSmithKline Pharmaceuticals

analysis to GlaxoSmithKline Pharmaceuticals

more news by category